The Biden administration has allocated $306 million in its final days as the ruling party of the United States, to the bird flu plandemic response. The “critical” funding comes as the H5N1 avian influenza outbreak continues and will go toward developing a response to the virus.

That response is going to include another “vaccine.” That new shot will likely be just as safe and effective as the mRNA COVID-19 injection.

It is still unknown whether the incoming Trump administration will continue such work. About $183 million of the new funding will go toward pandemic preparedness, especially treatment, at the regional, state, and local levels, while $103 million will be spent monitoring people who have been exposed to the bird flu virus. Another $8 million will go to test manufacturing and distribution, and $11 million is set aside for research on how to combat H5N1.

“These investments are critical to continuing our disease surveillance, laboratory testing, and monitoring efforts alongside our partners at USDA,” Xavier Becerra, secretary of the US Department of Health and Human Services (HHS), said in a statement according to the Guardian.

The new funding will be distributed within weeks and because the money has already been appropriated, it cannot legally be reversed if the incoming Trump administration lays out diverging priorities. –Guardian

So far, the Biden administration has spent about $1.8 billion responding to the bird flu outbreak. The majority of those funds have gone to the US Department of Agriculture (USDA) to address the outbreak among animals. About $360m of those funds have gone toward human health in this outbreak, which means the new allocation nearly doubles the total amount committed to curtailing bird flu in people. That includes the stockpiling of a “vaccine” for both poultry and humans.

CDC “Investigating” Whether The Bird Flu “Vaccine” Stockpile Is “Well Matched” To The Virus

BIRD FLU: The U.S. Will Build A NEW Stockpile Of Vaccines For Poultry

“I’m thrilled to see this funding made available and I hope that the new administration leans into it to strengthen our ongoing monitoring of the spread of the disease and our ability to stay alert for human cases,” said Megan Ranney, emergency physician and dean of the Yale School of Public Health.

“I worry that the virus is already widespread amongst animal reservoirs in the U.S., so there’s a little bit of luck now in whether or not it turns into a pandemic,” Ranney said. “It could have potentially been averted had we acted more aggressively six or nine months ago.”

The narrative is being built, however, this time, it is a much more slow rollout than the COVID-19 scamdemic.